30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Innoviva Inc (INVA)

Track

The most recent insider trading activity occurred on March 6, 2025, with Alexander J. Denner selling shares valued at over $20.9 million. Prior to this, significant sell transactions by Mr. Denner took place on March 5 and 4, 2025. Earlier in 2023, Mr. Denner engaged in multiple buy transactions.
Stock chart
Ticker: INVA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
DENNER ALEXANDER J
1 sale — total 20,964,237 USD
Sale 6 Mar 2025
Value US$4,252,001.07 | Price 496.87 | Shares 95,779
Sale 5 Mar 2025
Value US$2,308,289.96 | Price 122.57 | Shares 84,157
Sale 4 Mar 2025
Value US$2,665,079.19 | Price 17.63 | Shares 151,175
Sale 15 Nov 2023
Value US$75,507.85 | Price 13.97 | Shares 5,405
Sale 15 Nov 2023
Value US$78,301.89 | Price 14.01 | Shares 5,589
Buy 15 Jun 2023
Value US$814,196.40 | Price 13.13 | Shares 62,000
Buy 6 Jun 2023
Value US$104,384.00 | Price 13.05 | Shares 8,000
Buy 5 Jun 2023
Value US$91,296.80 | Price 13.04 | Shares 7,000
Buy 30 May 2023
Value US$1,560,648.00 | Price 13.01 | Shares 120,000
Buy 26 May 2023
Value US$393,729.00 | Price 13.12 | Shares 30,000
Buy 25 May 2023
Value US$654,330.00 | Price 13.09 | Shares 50,000
Buy 18 May 2023
Value US$130,538.00 | Price 13.05 | Shares 10,000
Buy 17 May 2023
Value US$653,690.00 | Price 13.07 | Shares 50,000
Buy 11 May 2023
Value US$3,577,411.00 | Price 12.34 | Shares 290,000
Planned buy 10 Mar 2023
Value US$32,603.10 | Price 10.87 | Shares 3,000
Buy 24 May 2021
Value US$134,619.00 | Price 13.46 | Shares 10,000
Buy 21 May 2021
Value US$129,670.00 | Price 12.97 | Shares 10,000
Sale 20 May 2021
Value US$392,064,435.00 | Price 12.25 | Shares 32,005,260
Sale 24 Feb 2020
Value US$43,660.12 | Price 14.78 | Shares 2,954
Buy 27 Feb 2019
Value US$238,500.00 | Price 15.90 | Shares 15,000
Sale 26 Feb 2019
Value US$89,872.00 | Price 16.00 | Shares 5,617
Buy 21 Feb 2019
Value US$148,958.00 | Price 14.90 | Shares 10,000
Buy 15 Feb 2019
Value US$103,600.00 | Price 14.80 | Shares 7,000
Planned sale 21 Aug 2018
Value US$112,840.00 | Price 14.11 | Shares 8,000
Sale 21 Aug 2018
Value US$120,079.88 | Price 14.12 | Shares 8,504
Planned sale 21 May 2018
Value US$115,202.40 | Price 14.40 | Shares 8,000
Planned sale 21 May 2018
Value US$83,623.00 | Price 14.40 | Shares 5,808
Planned sale 21 Feb 2018
Value US$164,148.29 | Price 16.60 | Shares 9,890
Planned sale 21 Feb 2018
Value US$132,100.00 | Price 16.51 | Shares 8,000
Planned sale 21 Feb 2018
Value US$88,825.20 | Price 16.52 | Shares 5,378
Sale 4 Dec 2017
Value US$157,791.15 | Price 13.13 | Shares 12,022
Planned sale 21 Nov 2017
Value US$172,794.70 | Price 13.29 | Shares 13,000
Planned sale 21 Nov 2017
Value US$69,145.16 | Price 13.26 | Shares 5,215
Planned sale 21 Nov 2017
Value US$179,171.44 | Price 13.31 | Shares 13,460
Planned sale 20 Nov 2017
Value US$23,798.00 | Price 13.04 | Shares 1,825
Planned sale 21 Aug 2017
Value US$22,265.00 | Price 12.20 | Shares 1,825
Planned sale 22 May 2017
Value US$93,858.15 | Price 12.01 | Shares 7,815
Planned sale 22 May 2017
Value US$21,626.25 | Price 11.85 | Shares 1,825
Planned sale 21 Feb 2017
Value US$22,027.75 | Price 12.07 | Shares 1,825
Planned sale 22 Nov 2016
Value US$40,122.80 | Price 10.84 | Shares 3,700
Planned sale 21 Nov 2016
Value US$19,602.00 | Price 10.89 | Shares 1,800
Planned sale 22 Aug 2016
Value US$43,549.00 | Price 11.77 | Shares 3,700
Planned sale 18 May 2016
Value US$8,512.11 | Price 10.47 | Shares 813
Sale 27 May 2015
Value US$266,228.16 | Price 16.32 | Shares 16,313
Sale 13 Aug 2014
Value US$1,202,040.00 | Price 22.50 | Shares 53,424
Sale 12 Aug 2014
Value US$23,370.40 | Price 22.30 | Shares 1,048
Sale 11 Aug 2014
Value US$599,628.96 | Price 22.12 | Shares 27,108
Planned sale 3 Mar 2014
Value US$67,014.00 | Price 37.23 | Shares 1,800
Planned sale 3 Mar 2014
Value US$2,350,300.32 | Price 36.72 | Shares 64,006
Planned sale 14 Feb 2014
Value US$184,184.00 | Price 40.04 | Shares 4,600
Sale 7 Jun 2013
Value US$1,087,571.52 | Price 35.04 | Shares 31,038
Planned sale 13 May 2013
Value US$650,482.57 | Price 40.33 | Shares 16,129
Planned sale 3 May 2013
Value US$560,805.33 | Price 34.77 | Shares 16,129
Planned sale 30 Apr 2013
Value US$6,868.00 | Price 34.34 | Shares 200
Planned sale 30 Apr 2013
Value US$3,435.00 | Price 34.35 | Shares 100
Planned sale 30 Apr 2013
Value US$574,055.04 | Price 33.76 | Shares 17,004
Planned sale 30 Apr 2013
Value US$346,834.00 | Price 34.34 | Shares 10,100
Planned sale 30 Apr 2013
Value US$5,429,506.83 | Price 33.77 | Shares 160,779
Planned sale 30 Apr 2013
Value US$54,122.64 | Price 34.32 | Shares 1,577
Planned sale 30 Apr 2013
Value US$8,543,046.20 | Price 33.64 | Shares 253,955
Planned sale 20 Feb 2013
Value US$154,980.00 | Price 22.14 | Shares 7,000
Planned sale 2 Nov 2012
Value US$4,506.00 | Price 22.53 | Shares 200
Planned sale 27 Aug 2012
Value US$79,707.46 | Price 27.86 | Shares 2,861
Planned sale 27 Aug 2012
Value US$482,148.00 | Price 27.24 | Shares 17,700
Planned sale 24 Aug 2012
Value US$115,429.21 | Price 28.01 | Shares 4,121
Planned sale 13 Aug 2012
Value US$81,274.20 | Price 26.15 | Shares 3,108
Planned sale 7 Aug 2012
Value US$1,622,400.00 | Price 27.04 | Shares 60,000
Planned sale 3 Aug 2012
Value US$3,459,762.64 | Price 27.92 | Shares 123,917
Planned sale 3 Aug 2012
Value US$1,019,030.00 | Price 28.15 | Shares 36,200
Planned sale 3 Aug 2012
Value US$1,098,275.73 | Price 27.77 | Shares 39,549
Sale 29 May 2012
Value US$445,800.00 | Price 22.29 | Shares 20,000
Buy 16 May 2012
Value US$212,887,000.00 | Price 21.29 | Shares 10,000,000
Sale 1 May 2012
Value US$186,402.06 | Price 21.71 | Shares 8,586
Sale 9 Dec 2011
Value US$218,600.00 | Price 21.86 | Shares 10,000
Planned sale 28 Nov 2011
Value US$420,000.00 | Price 21.00 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-06 2025-03-06 S Sale
2.8
DENNER ALEXANDER J
Large shareholder
95,779 +1.3%
496.87
US$4,252,001 		95,779 +1.3% 496.87 US$4,252,001
2025-03-06 2025-03-05 S Sale
2.8
DENNER ALEXANDER J
Large shareholder
84,157 -0.5%
122.57
US$2,308,290 		84,157 -0.5% 122.57 US$2,308,290
2025-03-06 2025-03-04 S Sale
2.8
DENNER ALEXANDER J
Large shareholder
59,108 +9.9%
141.83
US$1,180,684 		59,108 +9.9% 141.83 US$1,180,684
2023-11-17 2023-11-15 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
5,405 -11.9%
13.97
US$75,508 		5,405 -11.9% 13.97 US$75,508
2023-11-17 2023-11-15 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
5,589 -10.9%
14.01
US$78,302 		5,589 -10.9% 14.01 US$78,302
2023-06-20 2023-06-15 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
62,000 +0.9%
13.13
US$814,196 		62,000 +0.9% 13.13 US$814,196
2023-06-07 2023-06-06 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
8,000 +0.1%
13.05
US$104,384 		8,000 +0.1% 13.05 US$104,384
2023-06-07 2023-06-05 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
7,000 +0.1%
13.04
US$91,297 		7,000 +0.1% 13.04 US$91,297
2023-05-30 2023-05-30 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
120,000 +1.7%
13.01
US$1,560,648 		120,000 +1.7% 13.01 US$1,560,648
2023-05-30 2023-05-26 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
30,000 +0.4%
13.12
US$393,729 		30,000 +0.4% 13.12 US$393,729
2023-05-30 2023-05-25 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
50,000 +0.7%
13.09
US$654,330 		50,000 +0.7% 13.09 US$654,330
2023-05-19 2023-05-18 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
10,000 +0.1%
13.05
US$130,538 		10,000 +0.1% 13.05 US$130,538
2023-05-19 2023-05-17 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
50,000 +0.7%
13.07
US$653,690 		50,000 +0.7% 13.07 US$653,690
2023-05-15 2023-05-11 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
290,000 +4.4%
12.34
US$3,577,411 		290,000 +4.4% 12.34 US$3,577,411
2023-03-14 2023-03-10 PP Planned purchase
Raifeld Pavel

Chief Executive Officer

Officer
3,000 +44.1%
10.87
US$32,603 		3,000 +44.1% 10.87 US$32,603
2021-05-25 2021-05-24 B Purchase
2.9
Bickerstaff George
Non-Executive Director
10,000 +8.7%
13.46
US$134,619 		10,000 +8.7% 13.46 US$134,619
2021-05-25 2021-05-21 B Purchase
2.9
Bickerstaff George
Non-Executive Director
10,000 +9.6%
12.97
US$129,670 		10,000 +9.6% 12.97 US$129,670
2021-05-24 2021-05-20 S Sale
2.3
GLAXOSMITHKLINE PLC
Large shareholder
32,005,260 -100.0%
12.25
US$392,064,435 		32,005,260 -100.0% 12.25 US$392,064,435
2020-02-24 2020-02-24 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
2,954 -11.9%
14.78
US$43,660 		2,954 -11.9% 14.78 US$43,660
2019-02-28 2019-02-27 B Purchase
2.9
Bickerstaff George
Non-Executive Director
15,000 +38.7%
15.90
US$238,500 		15,000 +38.7% 15.90 US$238,500
2019-02-28 2019-02-26 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
5,617 -23.1%
16.00
US$89,872 		5,617 -23.1% 16.00 US$89,872
2019-02-22 2019-02-21 B Purchase
2.9
Bickerstaff George
Non-Executive Director
10,000 +34.8%
14.90
US$148,958 		10,000 +34.8% 14.90 US$148,958
2019-02-20 2019-02-15 B Purchase
1.5
HULME GEOFFREY

Interim PEO

Officer
7,000 +inf%
14.80
US$103,600 		7,000 +inf% 14.80 US$103,600
2018-08-22 2018-08-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer

Officer
8,000 -2.7%
14.11
US$112,840 		8,000 -2.7% 14.11 US$112,840
2018-08-22 2018-08-21 S Sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.

Officer
8,504 -3.3%
14.12
US$120,080 		8,504 -3.3% 14.12 US$120,080
2018-05-22 2018-05-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer

Officer
8,000 -2.6%
14.40
US$115,202 		8,000 -2.6% 14.40 US$115,202
2018-05-22 2018-05-21 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
5,808 -1.5%
14.40
US$83,623 		5,808 -1.5% 14.40 US$83,623
2018-02-22 2018-02-21 PlS Planned sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.

Officer
9,890 -5.0%
16.60
US$164,148 		9,890 -5.0% 16.60 US$164,148
2018-02-22 2018-02-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer

Officer
8,000 -3.3%
16.51
US$132,100 		8,000 -3.3% 16.51 US$132,100
2018-02-22 2018-02-21 PlS Planned sale dEsparbes Eric

Interim PEO, SVP and CFO

Officer
5,378 -1.8%
16.52
US$88,825 		5,378 -1.8% 16.52 US$88,825
2017-12-05 2017-12-04 S Sale Aguiar Michael W

President & Chief Exec Officer

Executive Director
12,022 -1.2%
13.13
US$157,791 		12,022 -1.2% 13.13 US$157,791
2017-11-22 2017-11-21 PlS Planned sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.
13,000 -5.7%
13.29
US$172,795 		13,000 -5.7% 13.29 US$172,795
2017-11-22 2017-11-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer
5,215 -2.0%
13.26
US$69,145 		5,215 -2.0% 13.26 US$69,145
2017-11-22 2017-11-21 PlS Planned sale dEsparbes Eric

SVP and CFO
13,460 -4.0%
13.31
US$179,171 		13,460 -4.0% 13.31 US$179,171
2017-11-22 2017-11-20 PlS Planned sale dEsparbes Eric

SVP and CFO
1,825 -0.5%
13.04
US$23,798 		1,825 -0.5% 13.04 US$23,798
2017-08-22 2017-08-21 PlS Planned sale dEsparbes Eric

SVP and CFO
1,825 -0.5%
12.20
US$22,265 		1,825 -0.5% 12.20 US$22,265
2017-05-23 2017-05-22 PlS Planned sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.

Officer
7,815 -3.1%
12.01
US$93,858 		7,815 -3.1% 12.01 US$93,858
2017-05-23 2017-05-22 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
1,825 -0.5%
11.85
US$21,626 		1,825 -0.5% 11.85 US$21,626
2017-02-22 2017-02-21 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
1,825 -0.5%
12.07
US$22,028 		1,825 -0.5% 12.07 US$22,028
2016-11-22 2016-11-22 PlS Planned sale WITEK THEODORE L JR

Sr. VP & Chief Scientific Off.

Officer
3,700 -2.4%
10.84
US$40,123 		3,700 -2.4% 10.84 US$40,123
2016-11-22 2016-11-21 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
1,800 -0.8%
10.89
US$19,602 		1,800 -0.8% 10.89 US$19,602
2016-08-23 2016-08-22 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
3,700 -1.5%
11.77
US$43,549 		3,700 -1.5% 11.77 US$43,549
2016-05-20 2016-05-18 PlS Planned sale Tyree James L Non-Executive Director
813 -1.6%
10.47
US$8,512 		813 -1.6% 10.47 US$8,512
2015-05-29 2015-05-27 S Sale WALTRIP WILLIAM H Non-Executive Director
16,313 -11.7%
16.32
US$266,228 		16,313 -11.7% 16.32 US$266,228
2014-08-15 2014-08-13 S Sale LEE JUNNING

Sr. VP, Technical Operations

Officer
53,424 -16.8%
22.50
US$1,202,040 		53,424 -16.8% 22.50 US$1,202,040
2014-08-13 2014-08-12 S Sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
1,048 -0.2%
22.30
US$23,370 		1,048 -0.2% 22.30 US$23,370
2014-08-13 2014-08-11 S Sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
27,108 -5.7%
22.12
US$599,629 		27,108 -5.7% 22.12 US$599,629
2014-03-05 2014-03-03 PlS Planned sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
1,800 -0.5%
37.23
US$67,014 		1,800 -0.5% 37.23 US$67,014
2014-03-05 2014-03-03 PlS Planned sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
64,006 -16.3%
36.72
US$2,350,300 		64,006 -16.3% 36.72 US$2,350,300
2014-02-19 2014-02-14 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
4,600 -2.4%
40.04
US$184,184 		4,600 -2.4% 40.04 US$184,184
2013-06-11 2013-06-07 S Sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
31,038 -9.3%
35.04
US$1,087,572 		31,038 -9.3% 35.04 US$1,087,572
2013-05-15 2013-05-13 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
16,129 -22.7%
40.33
US$650,483 		16,129 -22.7% 40.33 US$650,483
2013-05-07 2013-05-03 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
16,129 -22.7%
34.77
US$560,805 		16,129 -22.7% 34.77 US$560,805
2013-05-02 2013-04-30 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
200 -0.1%
34.34
US$6,868 		200 -0.1% 34.34 US$6,868
2013-05-02 2013-04-30 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
100 -0.2%
34.35
US$3,435 		100 -0.2% 34.35 US$3,435
2013-05-02 2013-04-30 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
17,004 -23.6%
33.76
US$574,055 		17,004 -23.6% 33.76 US$574,055
2013-05-02 2013-04-30 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
10,100 -6.6%
34.34
US$346,834 		10,100 -6.6% 34.34 US$346,834
2013-05-02 2013-04-30 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
160,779 -51.3%
33.77
US$5,429,507 		160,779 -51.3% 33.77 US$5,429,507
2013-05-02 2013-04-30 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
1,577 -0.2%
34.32
US$54,123 		1,577 -0.2% 34.32 US$54,123
2013-05-02 2013-04-30 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
253,955 -26.0%
33.64
US$8,543,046 		253,955 -26.0% 33.64 US$8,543,046
2013-02-22 2013-02-20 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
7,000 -3.2%
22.14
US$154,980 		7,000 -3.2% 22.14 US$154,980
2012-11-06 2012-11-02 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
200 -0.1%
22.53
US$4,506 		200 -0.1% 22.53 US$4,506
2012-08-28 2012-08-27 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
2,861 -2.1%
27.86
US$79,707 		2,861 -2.1% 27.86 US$79,707
2012-08-28 2012-08-27 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
17,700 -11.6%
27.24
US$482,148 		17,700 -11.6% 27.24 US$482,148
2012-08-28 2012-08-24 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
4,121 -2.6%
28.01
US$115,429 		4,121 -2.6% 28.01 US$115,429
2012-08-15 2012-08-13 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
3,108 -1.4%
26.15
US$81,274 		3,108 -1.4% 26.15 US$81,274
2012-08-09 2012-08-07 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
60,000 -27.5%
27.04
US$1,622,400 		60,000 -27.5% 27.04 US$1,622,400
2012-08-07 2012-08-03 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
123,917 -65.0%
27.92
US$3,459,763 		123,917 -65.0% 27.92 US$3,459,763
2012-08-07 2012-08-03 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
36,200 -5.8%
28.15
US$1,019,030 		36,200 -5.8% 28.15 US$1,019,030
2012-08-07 2012-08-03 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
39,549 -5.9%
27.77
US$1,098,276 		39,549 -5.9% 27.77 US$1,098,276
2012-05-31 2012-05-29 S Sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
20,000 -11.2%
22.29
US$445,800 		20,000 -11.2% 22.29 US$445,800
2012-05-16 2012-05-16 B Purchase GLAXOSMITHKLINE PLC Large shareholder
10,000,000 +63.2%
21.29
US$212,887,000 		10,000,000 +63.2% 21.29 US$212,887,000
2012-05-02 2012-05-01 S Sale DRAZAN JEFFREY M Non-Executive Director
8,586 -20.4%
21.71
US$186,402 		8,586 -20.4% 21.71 US$186,402
2011-12-13 2011-12-09 S Sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
10,000 -5.1%
21.86
US$218,600 		10,000 -5.1% 21.86 US$218,600
2011-11-30 2011-11-28 PlS Planned sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
20,000 -5.4%
21.00
US$420,000 		20,000 -5.4% 21.00 US$420,000
Explore more

More insider trading research around Innoviva Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America